ArticleBulletin of the Korean Chemical Society2019
Study on the 2-Phenylchroman-4-One Derivatives and their
Article in Bulletin of the Korean Chemical Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Enhancing the Dispersibility and Stability of Graphene in Water Using Porphyrin-Based Compounds.Small methods · 2025Article
- Shedding light on the use of graphene oxide-thiosemicarbazone hybrids towards the rapid immobilisation of methylene blue and functional coumarins.Nanoscale advances · 2024Article
- Aromatic C-H bond functionalization through organocatalyzed asymmetric intermolecular aza-Friedel-Crafts reaction: a recent update.Beilstein journal of organic chemistry · 2023Review
- Synthesis and biological evaluation of 2-benzylaminoquinazolin-4(3Bulletin of the Korean Chemical Society · 2022Article
- Discovery of a subtype-selective, covalent inhibitor against palmitoylation pocket of TEAD3.Acta pharmaceutica Sinica. B · 2021Article
- Recent development and applications of semipinacol rearrangement reactions.Chemical science · 2021Review
- Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments.Bioorganic & medicinal chemistry letters · 2021Article
- Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors.Bioorganic & medicinal chemistry letters · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Study on the 2-phenylchroman-4-one derivatives and their anti-MERS-CoVactivities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.